News | Görlich Gruppe

BioTech-Fonds Görlich GmbH & Co. 1st BioTech KG is aimed exclusively at professional and semi-professional investors within the meaning of the German Investment Code (section 1 (19) no. 32, 33 KAGB). Among other things, a semi-professional investor undertakes to invest at least EUR 200,000 and must have the necessary expertise, experience and knowledge to make such an investment.

Please select your investor type

Private Investor

(Semi-)professional or institutional investor according to KAGB

I have read and understood the restrictions of use and conditions. I consent to the processing of personal data.

The content of this site is aimed exclusively at professional and semi-professional investors within the meaning of the KAGB.

I understood

The BioTech-Fonds Görlich GmbH & Co. 1. BioTech KG is aimed exclusively at investors who are not citizens of the exclusion states USA, Canada, Australia, Japan, Belarus oder Russia.

By clicking on continue, I confirm that I am not a citizen of one of the excluded countries.

Görlich Group news at a glance

Neue Therapie nach einem Herzinfarkt